COMMUNIQUÉS West-GlobeNewswire

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
18/12/2025
CONSHOHOCKEN, Pa., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
vTv Therapeutics and M42’s IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health
18/12/2025
Trial to assess cadisegliatin as potential adjunctive therapy to insulin in patients with T2D HIGH POINT, N.C., Dec. 18, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical [...]
AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
18/12/2025
VALENCIA, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- AVITA Medical ® , Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced that Cary Vance, [...]
Crescent Biopharma Announces Grants of Inducement Awards
18/12/2025
WALTHAM, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer [...]
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/12/2025
FOSTER CITY, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that, effective December 17, 2025, it granted stock options to [...]
Annovis Announces Open-Label Extension Study for Parkinson's Disease Patients
18/12/2025
Enrollment will begin in January 2026 Participants will be treated with buntanetap for 36 months The study aims to enroll 500 patients MALVERN, Pa., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“ [...]
Senti Biosciences Announces New Employment Inducement Grants
18/12/2025
SOUTH SAN FRANCISCO, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its [...]
Nxera Pharma to Regain Full Rights to GPR52 Agonist Program for Schizophrenia
19/12/2025
Tokyo, Japan and Cambridge, UK, 19 December 2025 – Nxera Pharma Co. Ltd (“Nxera” or “the Company; TSE 4565) today announces that Boehringer Ingelheim has informed the Company of its decision not to exercise its [...]
CARBIOS maintient son objectif de construction de l’usine de Longlaville avec un calendrier ajusté
18/12/2025
CARBIOS réaffirme son ambition de poursuivre le projet de construction de l’usine à Longlaville en décalant le calendrier prévisionnel de trois mois. Le projet de construction de l’usine est aujourd’hui conforté par : [...]
CARBIOS maintains its commitment to build the Longlaville plant and adjusts its timeline
18/12/2025
CARBIOS reaffirms its ambition to pursue the Longlaville plant construction project and postpones the timeline by three-month. The plant construction project is supported by: Pre-commercialization contracts covering [...]
ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK
18/12/2025
Peak Medical, ENvue’s Exclusive Distributor in UK, Places Significant Order after Reimbursement Decision, Projecting Future Market Demand for UroShield® Kit TYLER, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) -- ENvue Medical [...]
AB Science annonce l’initiation de la couverture de son titre par Maxim Group avec un objectif de cours de 4,0 euros par action
18/12/2025
COMMUNIQUÉ DE PRESSE AB SCIENCE ANNONCE L’INITIATION DE LA COUVERTURE DE SON TITRE PAR MAXIM GROUP AVEC UN OBJECTIF DE COURS DE 4,0 EUROS PAR ACTION Paris, le 18 décembre 2025, 19h15 CET AB Science SA (Euronext - [...]
AB Science announces the initiation of coverage of its stock by Maxim Group with a target price of EUR 4.0 per share
18/12/2025
PRESS RELEASE AB SCIENCE ANNOUNCES THE INITIATION OF COVERAGE OF ITS STOCK BY MAXIM GROUP WITH A TARGET PRICE OF EUR 4.0 PER SHARE Paris, December 18, 2025, 7.15pm CET AB Science SA (Euronext - FR0010557264 - AB) [...]
Tilray Accelerates U.S. Medical Cannabis Expansion After Landmark Federal Rescheduling: Launches Tilray Medical USA to Lead Nationwide Medical Cannabis Innovation and Growth
18/12/2025
Global Cannabis Leader Poised for Major U.S. Market Entry, Signaling New Era for Healthcare NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. (“Tilray” or the “Company”) ( [...]
Celularity Reaches Binding Term Sheets on Financing Transactions to Support Its Strategic Vision
18/12/2025
The contemplated financing transactions would provide up to $12 Million in capital to support Celularity’s strategic priorities around longevity and preservation of human performance. FLORHAM PARK, N.J., Dec. 18, 2025 ( [...]
Organic & Natural Health to Address Policy, Integrity and Innovation at 2026 Industry Conference
18/12/2025
FT. LAUDERDALE, Fla., Dec. 18, 2025 (GLOBE NEWSWIRE) -- The Organic & Natural Health Association (Organic & Natural Health) will convene industry leaders, policymakers and changemakers for its 11th Annual [...]
Verano Founder and Chief Executive Officer George Archos Shares Celebratory Comments on Cannabis Rescheduling Announcement
18/12/2025
Verano’s active operations span 13 states, comprised of 15 8 dispensaries operating under the Zen Leaf ™ and MÜV ™ retail banners, and 15 cultivation and processing facilities with more than 1.1 million square feet of [...]
Foundation for Sarcoidosis Research Publishes Comprehensive Voice of the Patient Report Following Externally Led PFDD Meeting with the FDA
18/12/2025
CHICAGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is proud to announce the release of its comprehensive Voice of the Patient report , capturing the powerful insights, lived [...]
Bavarian Nordic Establishes Long-term Incentive Program for Members of Executive Management and Selected Employees
18/12/2025
COPENHAGEN, Denmark, December 18, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Board of Directors has decided to establish a long-term incentive program for Executive Management as part of the annual [...]

Pages